Agreement Provides Opportunities to Expand Performance and Applications of Nanomaterials

Zyvex Performance Materials, a recognized worldwide leader in nanomaterials applications, announced an agreement with Lockheed Martin for nano-enhanced composite materials. The cooperation agreement between Lockheed Martin and Zyvex Performance Materials provides opportunities to expand the capabilities and performance of nanomaterials and their applications.

“We are very excited to be working with Lockheed Martin to further develop our technology, and offer their customers improved products to help them achieve their most challenging goals,” says Lance Criscuolo, President of Zyvex Performance Materials. “By combining efforts with Lockheed Martin, we will be able to accelerate the performance of our materials and integrate them into a variety of commercial applications.”

“Lockheed Martin is proud to enter into this collaboration with Zyvex,” said Brad Pietras, Director of Nanotechnology Programs at Lockheed Martin. “We look forward to incorporating Zyvex Performance Materials’ technology into products and services that are important to national security.”

Headquartered in Bethesda, Md., Lockheed Martin employs about 140,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services. The corporation reported 2007 sales of $41.9 billion.

Based in Columbus, Ohio, Zyvex Performance Materials Inc., was spun out of Zyvex Corporation in April 2007. Zyvex Performance Materials is focused on developing nanotechnology to improve the properties of composite materials. The company’s patented technology allows composites to take advantage of the superior physical and chemical properties of carbon nanotubes by enabling the even dispersion of carbon nanotubes in composites mixtures. Zyvex Performance Materials was the first company to provide carbon nanotube enhanced products to the marketplace.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.